153 related articles for article (PubMed ID: 22474474)
1. Beneficial effects of melatonin on stroke-induced muscle atrophy in focal cerebral ischemic rats.
Lee S; Shin J; Hong Y; Lee M; Kim K; Lee SR; Chang KT; Hong Y
Lab Anim Res; 2012 Mar; 28(1):47-54. PubMed ID: 22474474
[TBL] [Abstract][Full Text] [Related]
2. Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3.
López-Menduiña M; Martín AI; Castillero E; Villanúa MA; López-Calderón A
Am J Physiol Regul Integr Comp Physiol; 2010 Aug; 299(2):R541-51. PubMed ID: 20519361
[TBL] [Abstract][Full Text] [Related]
3. Effects of insulin-like growth factor 1 on muscle atrophy and motor function in rats with brain ischemia.
Chang HC; Yang YR; Wang PS; Kuo CH; Wang RY
Chin J Physiol; 2010 Oct; 53(5):337-48. PubMed ID: 21793345
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of endogenous and exogenous melatonin on neural reconstruction and functional recovery in an animal model of spinal cord injury.
Park S; Lee SK; Park K; Lee Y; Hong Y; Lee S; Jeon JC; Kim JH; Lee SR; Chang KT; Hong Y
J Pineal Res; 2012 Jan; 52(1):107-19. PubMed ID: 21854445
[TBL] [Abstract][Full Text] [Related]
5. Melanocortin-4 receptor agonist (RO27-3225) ameliorates soleus but not gastrocnemius atrophy in arthritic rats.
Gomez-Sanmiguel AB; Nieto-Bona MP; Fernandez-Galaz C; Priego T; Martin AI; Lopez-Calderon A
J Physiol Pharmacol; 2017 Apr; 68(2):191-199. PubMed ID: 28614768
[TBL] [Abstract][Full Text] [Related]
6. Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation.
Granado M; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1656-65. PubMed ID: 17284570
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle.
Granado M; Priego T; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E1007-14. PubMed ID: 16030067
[TBL] [Abstract][Full Text] [Related]
8. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
Baehr LM; Furlow JD; Bodine SC
J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
[TBL] [Abstract][Full Text] [Related]
9. PI3 kinase regulation of skeletal muscle hypertrophy and atrophy.
Glass DJ
Curr Top Microbiol Immunol; 2010; 346():267-78. PubMed ID: 20593312
[TBL] [Abstract][Full Text] [Related]
10. [Effect of electroacupuncture on degradation of myosin heavy chain of gastrocnemius muscle in diabetes rats].
Chen XL; Wu ZH; Fan R; Zou ZQ; Long ZY; Yao L; Li B
Zhen Ci Yan Jiu; 2019 Sept 25; 44(9):653-8. PubMed ID: 31532134
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3β is required for the induction of skeletal muscle atrophy.
Verhees KJ; Schols AM; Kelders MC; Op den Kamp CM; van der Velden JL; Langen RC
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C995-C1007. PubMed ID: 21832246
[TBL] [Abstract][Full Text] [Related]
12. Atrogin-1/MAFbx and MuRF1 are downregulated in aging-related loss of skeletal muscle.
Edström E; Altun M; Hägglund M; Ulfhake B
J Gerontol A Biol Sci Med Sci; 2006 Jul; 61(7):663-74. PubMed ID: 16870627
[TBL] [Abstract][Full Text] [Related]
13.
Yang L; Jiang X; Fu S; Tan J; Dian W; Zhou Y
Discov Med; 2024 Feb; 36(181):402-414. PubMed ID: 38409845
[TBL] [Abstract][Full Text] [Related]
14. Exogenous insulin-like growth factor 1 attenuates cisplatin-induced muscle atrophy in mice.
Sakai H; Asami M; Naito H; Kitora S; Suzuki Y; Miyauchi Y; Tachinooka R; Yoshida S; Kon R; Ikarashi N; Chiba Y; Kamei J
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1570-1581. PubMed ID: 34268902
[TBL] [Abstract][Full Text] [Related]
15. Severe atrophy of slow myofibers in aging muscle is concealed by myosin heavy chain co-expression.
Purves-Smith FM; Solbak NM; Rowan SL; Hepple RT
Exp Gerontol; 2012 Dec; 47(12):913-8. PubMed ID: 22884852
[TBL] [Abstract][Full Text] [Related]
16. Effects of a novel selective androgen receptor modulator on dexamethasone-induced and hypogonadism-induced muscle atrophy.
Jones A; Hwang DJ; Narayanan R; Miller DD; Dalton JT
Endocrinology; 2010 Aug; 151(8):3706-19. PubMed ID: 20534726
[TBL] [Abstract][Full Text] [Related]
17. Muscle-specific and age-related changes in protein synthesis and protein degradation in response to hindlimb unloading in rats.
Baehr LM; West DWD; Marshall AG; Marcotte GR; Baar K; Bodine SC
J Appl Physiol (1985); 2017 May; 122(5):1336-1350. PubMed ID: 28336537
[TBL] [Abstract][Full Text] [Related]
18. Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophy.
Iyer CC; McGovern VL; Wise DO; Glass DJ; Burghes AH
Neuromuscul Disord; 2014 May; 24(5):436-44. PubMed ID: 24656734
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression of muscle-specific ubiquitin ligase MAFbx/Atrogin-1 and MuRF1 in response to immobilization-induced atrophy of slow-twitch and fast-twitch muscles.
Okamoto T; Torii S; Machida S
J Physiol Sci; 2011 Nov; 61(6):537-46. PubMed ID: 21901639
[TBL] [Abstract][Full Text] [Related]
20. Hormone, cytokine, and nutritional regulation of sepsis-induced increases in atrogin-1 and MuRF1 in skeletal muscle.
Frost RA; Nystrom GJ; Jefferson LS; Lang CH
Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E501-12. PubMed ID: 17003238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
